RHUMBLINE ADVISERS - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$20,402,000
+129.8%
239,936
-4.2%
0.03%
+113.3%
Q2 2020$8,879,000
+131.8%
250,525
-11.8%
0.02%
+87.5%
Q1 2020$3,830,000
-29.6%
284,122
+10.6%
0.01%
-11.1%
Q4 2019$5,438,000
+65.3%
256,999
+3.6%
0.01%
+50.0%
Q3 2019$3,290,000
-3.2%
248,123
+1.3%
0.01%0.0%
Q2 2019$3,398,000
-12.0%
244,985
+21.9%
0.01%
-14.3%
Q1 2019$3,860,000
+38.5%
200,933
+2.8%
0.01%
+16.7%
Q4 2018$2,788,000
+2.4%
195,374
+49.5%
0.01%
+20.0%
Q3 2018$2,723,000
-13.6%
130,715
-1.8%
0.01%
-16.7%
Q2 2018$3,150,000
+105.2%
133,069
+26.6%
0.01%
+100.0%
Q1 2018$1,535,000
-11.5%
105,071
-2.1%
0.00%
-25.0%
Q4 2017$1,735,000
-0.5%
107,351
-13.9%
0.00%0.0%
Q3 2017$1,744,000
+60.0%
124,726
+1.0%
0.00%
+100.0%
Q2 2017$1,090,000
+51.6%
123,491
+11.1%
0.00%0.0%
Q1 2017$719,000
+83.0%
111,116
+3.8%
0.00%
+100.0%
Q4 2016$393,000
+24.8%
107,009
+10.3%
0.00%0.0%
Q3 2016$315,000
+17.1%
97,018
-16.3%
0.00%0.0%
Q2 2016$269,000
+4.7%
115,948
+13.0%
0.00%0.0%
Q1 2016$257,000
-16.6%
102,635
+2.2%
0.00%0.0%
Q4 2015$308,000
+80.1%
100,435
+0.8%
0.00%0.0%
Q3 2015$171,000
-51.8%
99,640
+13.9%
0.00%0.0%
Q2 2015$355,000
+8.2%
87,448
+2.1%
0.00%0.0%
Q1 2015$328,000
-3.8%
85,643
+20.7%
0.00%0.0%
Q4 2014$341,000
+34.3%
70,943
+3.8%
0.00%0.0%
Q3 2014$254,000
+2.0%
68,3430.0%0.00%0.0%
Q2 2014$249,000
-7.8%
68,343
+6.7%
0.00%0.0%
Q1 2014$270,000
-13.2%
64,055
-5.3%
0.00%0.0%
Q4 2013$311,000
-27.5%
67,635
-2.3%
0.00%0.0%
Q3 2013$429,000
+14.7%
69,235
+0.8%
0.00%0.0%
Q2 2013$374,00068,7040.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders